Requirement for further validation on the seroconversion of hepatitis B surface antigen in successful vaccinees-Reference-Cited by-同舟云学术

Requirement for further validation on the seroconversion of hepatitis B surface antigen in successful vaccinees

Published:2021-05-14 Issue:8 Volume:17 Page:2773-2774
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Zeng Qing-Lei¹,Zhou Yi-Hua²³^ORCID

Affiliation:

1. Department of Infectious Diseases and Hepatology, The First Affiliated Hospital of Zhengzhou University, Henan, China

2. Department of Laboratory Medicine and Jiangsu Key Laboratory for Molecular Medicine, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, Jiangsu, China

3. Department of Infectious Diseases, Nanjing Drum Tower Hospital, Nanjing Medical University, Nanjing, Jiangsu, China

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2021.1889258

Reference10 articles.

1. Revaccination against hepatitis B in late teenagers who received vaccination during infancy: Yes or no?

2. Minimization of hepatitis B infection among children in Jiangsu, China, 12 years after integration of hepatitis B vaccine into the expanded program on immunization

3. Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China

4. Hepatitis B vaccine development and implementation

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elimination of hepatitis B virus infection in children: experience and challenge in China;Chinese Medical Journal;2021-10-11